Cell Therapy clinical trials

Explore recruiting cell therapy clinical trials.

Recruiting cell therapy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Cell Therapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase I Randomised Double-Blind Placebo Controlled Safety Study of Intramyocardial Injection of CLXR-001 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Hungary

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

A Phase 2, Multicohort Open-Label Study of JNJ-68284528, a Chimeric Antigen Receptor T cell (CAR-T) Therapy Directed Against BCMA in Subjects with Multiple Myeloma CARTITUDE-2

Spain, Netherlands, Germany, France, Belgium

Therapeutic exploratory (Phase II) EU CTIS Study details

Long-term follow-up of patients previously treated with autologous T cells genetically modified with viral vectors.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Single center, decentralized, parallel group, open, non-randomized, long-term safety follow-up, and exploratory study of long-term effects on inflammatory, immunological, and aging related biomarkers in study participants treated with MSCs.

Sweden

Phase III and phase IV (Integrated) EU CTIS Study details

Modified autologous leukocyte cells for the treatment of acute kidney injury after cardiac surgery

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Double-T - Improving outcomes in high-risk 2nd line relapsed/refractory Large B-Cell Lymphoma patients eligible for CAR-T-cell therapy with a Glofitamab-based induction and consolidation concept

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Cell Therapy trials by city

Cell Therapy in Toronto Cell Therapy in Vancouver Cell Therapy in Montreal Cell Therapy in Calgary Cell Therapy in Edmonton Cell Therapy in Ottawa Cell Therapy in Winnipeg Cell Therapy in Quebec City Cell Therapy in Hamilton Cell Therapy in Kitchener Cell Therapy in London Cell Therapy in Halifax Cell Therapy in New York Cell Therapy in Los Angeles Cell Therapy in Chicago Cell Therapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease